The day after Tom Holder spoke at the University of Pittsburgh about the importance of animal research, more news is coming from this academic institution. Every 45 seconds someone in the US gets a stroke, many are left paralyzed, furthermore 14,000 people every year suffer spinal cord injuries which may also result in paralysis. There … Continue reading Monkeys, Robots and the University of Pittsburgh – New hope for paralysis victims?
A diverse audience of approximately fifty researchers, animal care technicians and medical students, both undergraduates and postgraduates, attended the Speaking of Research presentation at Pittsburgh University. From "Science for the Non-scientist, a lesson in getting your message across" (summarized in our YouTube video), to "Pro-Test: the UK experience of the animal rights issue", and finally … Continue reading SR in Pittsburgh
Huntington's disease is an inherited neurological disease that affects about 30, 000 Americans and for which there is no effective treatment or cure. An important step to developing new treatments was announced last week when scientists at the Yerkes National Primate Research Center in Atlanta published a paper (1) describing how they genetically modified monkeys … Continue reading A monkey model of Huntington’s disease
On Tuesday, May 27th 2008, Speaking of Research founder, Tom Holder, will be speaking at Pittsburgh University (Note to self: Pittsburgh does not rhyme with Edinburgh). The presentation will take place at: S100a, Biomedical Science Tower (map). The order of the day is: 4:00 – 4:30 pm Introductions 4:30 – 5:30 pm Seminar 5:30 – … Continue reading SR in Pittsburgh – May 27th
The website has been undergoing some minor updates over the last few days. Check the (new) Calendar tab to see past and future presentations by Speaking of Research, clicking on past events will take you to the relevant blog/news post. Keep checking back for any updates (Information about an upcoming talk at Pittsburgh can be … Continue reading Updating the Website
Newspapers in the UK are buzzing with excitement over news that a new vaccine against meningitis B developed by the Swiss pharmaceuticals firm Novartis has performed well in early clinical trials. http://www.guardian.co.uk/society/2008/may/15/health.medicalresearch http://www.independent.co.uk/life-style/health-and-wellbeing/health-news/meningitis-defeated-at-last-828286.html About 3,000 mostly young people catch meningitis B every year in the USA, of whom about 10% die and 25% suffer lifelong … Continue reading A vaccine against meningitis B?
After a successful day on the Duke University campus (see previous post), I headed over to the Smithies & Maeda's Laboratories in the Department of Pathology and Laboratory Medicine at the University of North Carolina - Chapel Hill. Here I gave a presentation to Nobel Prize Laureate (For his work in introducing gene modifications into … Continue reading North Carolina: Day 2: UNC-Chapel Hill